Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hawley

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Cancer Medicine|November 7, 2019
Association between PSA values and surveillance quality after prostate cancer surgeryChristina Hunter Chapman, Megan E V Caram, Archana Radhakrishnan, et al.
Gastroenterology|August 19, 2023
Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health RecordsJoel H Rubenstein, Simon Fontaine, Peter W MacDonald, et al.
Implementation Science : IS|November 30, 2018
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)Ted A Skolarus, Sarah T Hawley, Daniela A Wittmann, et al.
Mucosal Immunology|December 26, 2013
The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cellsF Meylan, E T Hawley, L Barron, et al.
Molecular Cancer Therapeutics|September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient MiceCiersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
JAMA Internal Medicine|October 30, 2023
Personalized Multilevel Intervention for Improving Appropriate Use of Colorectal Cancer Screening in Older Adults: A Cluster Randomized Clinical TrialSameer D Saini, Carmen L Lewis, Eve A Kerr, et al.
Trials|February 11, 2023
The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trialLynette Hammond Gerido, Jennifer J Griggs, Ken Resnicow, et al.
Implementation Science Communications|October 29, 2021
Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
JCO Oncology Practice|May 23, 2023
Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology PracticesReshma Jagsi, Krithika Suresh, Chris D Krenz, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Cancer Medicine|November 7, 2019
Association between PSA values and surveillance quality after prostate cancer surgeryChristina Hunter Chapman, Megan E V Caram, Archana Radhakrishnan, et al.
Gastroenterology|August 19, 2023
Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health RecordsJoel H Rubenstein, Simon Fontaine, Peter W MacDonald, et al.
Implementation Science : IS|November 30, 2018
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)Ted A Skolarus, Sarah T Hawley, Daniela A Wittmann, et al.
Mucosal Immunology|December 26, 2013
The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cellsF Meylan, E T Hawley, L Barron, et al.
Molecular Cancer Therapeutics|September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient MiceCiersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
JAMA Internal Medicine|October 30, 2023
Personalized Multilevel Intervention for Improving Appropriate Use of Colorectal Cancer Screening in Older Adults: A Cluster Randomized Clinical TrialSameer D Saini, Carmen L Lewis, Eve A Kerr, et al.
Trials|February 11, 2023
The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trialLynette Hammond Gerido, Jennifer J Griggs, Ken Resnicow, et al.
Implementation Science Communications|October 29, 2021
Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
JCO Oncology Practice|May 23, 2023
Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology PracticesReshma Jagsi, Krithika Suresh, Chris D Krenz, et al.
Pageof 22